The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Health related quality of life (HRQoL) in patients with triple-class-exposed relapsed/refractory multiple myeloma (TCE RRMM) treated with idecabtagene vicleucel (ide-cel) versus standard regimens: Patient-reported outcomes (PROs) from KarMMa-3 phase 3 randomized controlled trial (RCT).
 
Michel Delforge
Honoraria - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Janssen; Sanofi; Stemline Therapeutics
Consulting or Advisory Role - Amgen; Bristol Myers Squibb Foundation; GlaxoSmithKline; Janssen; Sanofi; Stemline Therapeutics
 
Krina K. Patel
Consulting or Advisory Role - Arcellx; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Cellectis; Janssen; Karyopharm Therapeutics; Merck; Pfizer; Takeda; Takeda
Research Funding - Abbvie/Genentech; Allogene Therapeutics; Celgene/Bristol-Myers Squibb; Cellectis; Janssen; Nektar; Poseida; Precision Biosciences; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Laurie Eliason
Employment - Bristol Myers Squibb Foundation; GlaxoSmithKline
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation; GlaxoSmithKline
Honoraria - Bristol Myers Squibb Foundation; GlaxoSmithKline
 
Devender Dhanda
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
Research Funding - Bristol Myers Squibb Foundation
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Ling Shi
Employment - Evidera
 
Shien Guo
Employment - Evidera
Stock and Other Ownership Interests - Thermo Fisher Scientific
Consulting or Advisory Role - Bristol Myers Squibb Foundation
Research Funding - Bristol Myers Squibb Foundation
 
Thomas Marshall
Employment - Bristol Myers Squibb Foundation
Stock and Other Ownership Interests - Bristol Myers Squibb Foundation
 
Bertrand Arnulf
Honoraria - Celgene; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
Research Funding - Janssen-Cilag
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag; Takeda
 
Michele Cavo
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Mundipharma; Sanofi; Takeda
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Janssen
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Cellectar; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; ONK Therapeutics; Pfizer; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Salomon Manier
Consulting or Advisory Role - Adaptive Biotechnologies (Inst); Amgen (Inst); Celgene/Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Natalie Scott Callander
No Relationships to Disclose
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi
 
Hermann Einsele
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Novartis; Sanofi; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb; Celgene (Inst); GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Sanofi; Takeda
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); MedImmune (Inst); Pharmacyclics (Inst); Sanofi (Inst); Xencor (Inst)
 
Mihaela Popa McKiver
Employment - Briston Myers Squibb
Stock and Other Ownership Interests - Briston Myers Squibb
 
Mark Cook
Employment - Bristol Myers Squibb Foundation
 
Paula Rodríguez-Otero
Honoraria - Abbvie; Celgene; GlaxoSmithKline; H3 Biomedicine; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; BMS; GlaxoSmithKline; Janssen; Pfizer; Sanofi
Speakers' Bureau - BMS; GlaxoSmithKline; Janssen; Sanofi
Travel, Accommodations, Expenses - Pfizer